Clinical Trial Update: GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating genitourinary syndrome of menopause management in breast cancer survivors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Genitourinary Syndrome of Menopause

Snippet

Sponsor: Alta Bates Summit Medical Center | Conditions: Genitourinary Abnormality, Breast Cancer Female | EARLY_Phase 1 | Status: TERMINATED